Pictet Asset Management Holding SA Purchases 158,900 Shares of Teleflex Incorporated $TFX

Pictet Asset Management Holding SA boosted its position in Teleflex Incorporated (NYSE:TFX) by 2,289.0% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 165,842 shares of the medical technology company’s stock after purchasing an additional 158,900 shares during the period. Pictet Asset Management Holding SA owned about 0.37% of Teleflex worth $19,836,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Empowered Funds LLC grew its position in Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after buying an additional 230 shares during the period. Jane Street Group LLC grew its holdings in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after purchasing an additional 1,895 shares during the period. American Century Companies Inc. grew its holdings in Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after purchasing an additional 3,360 shares during the period. Invesco Ltd. increased its position in Teleflex by 1.2% in the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after buying an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in Teleflex by 108.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after buying an additional 521 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of TFX opened at $129.89 on Thursday. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $139.67. The stock’s 50-day simple moving average is $129.85 and its 200 day simple moving average is $119.63. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -5.70, a price-to-earnings-growth ratio of 0.94 and a beta of 0.82.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The business had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the previous year, the firm earned $1.44 EPS. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Mizuho set a $140.00 price objective on shares of Teleflex in a report on Friday, May 8th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a research note on Monday, April 13th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $140.00 to $160.00 in a report on Monday, June 8th. Finally, Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Teleflex presently has a consensus rating of “Hold” and an average price target of $146.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.